An International Collaborative Trial for relapsed Refractory Acute Lymphoblastic Leukaemia (ALL).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Asparaginase; Cyclophosphamide; Dexamethasone; Etoposide; Idarubicin; Methotrexate; Mitoxantrone; Pegaspargase; Prednisolone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms ALLR3
- 05 Nov 2013 Accrual to date is 82% according to United Kingdom Clinical Research Network record.
- 04 Oct 2013 Accrual to date is 81% according to United Kingdom Clinical Research Network record.
- 12 Aug 2013 Biomarkers information updated